UK markets close in 4 hours 40 minutes

Oncolytics Biotech Inc. (ONC.TO)

Toronto - Toronto Real-time price. Currency in CAD
Add to watchlist
1.5100-0.0400 (-2.58%)
At close: 03:59PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
19,913
17,709
15,432
12,920
12,945
Selling general and administrative
15,467
15,679
11,100
12,863
12,514
Total operating expenses
35,783
33,791
26,924
26,235
25,459
Operating income or loss
-35,783
-33,791
-26,924
-26,235
-25,459
Total other income/expenses net
6,164
4,810
1,645
-119
2,833
Income before tax
-28,112
-27,655
-24,751
-26,255
-22,505
Income tax expense
-
97
84
49
0
Income from continuing operations
-28,209
-27,752
-24,835
-26,304
-22,505
Net income
-28,209
-27,752
-24,835
-26,304
-22,505
Net income available to common shareholders
-28,209
-27,752
-24,835
-26,304
-22,505
Basic EPS
-0.51
-0.41
-0.43
-0.49
-0.56
Diluted EPS
-0.51
-0.41
-0.43
-0.49
-0.56
Basic average shares
64,057
67,624
58,030
53,513
40,339
Diluted average shares
64,057
67,624
58,030
53,513
40,339